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A diversity of recently reported methodology for
asymmetric imine reduction
Jonathan Barrios-Rivera, a Yingjian Xu,*b Martin Wills *a and Vijyesh K. Vyas a
This review contains an account of recent developments in catalytic, asymmetric processes reported for
the reduction of CvN bonds to amines, in which we have attempted to communicate the remarkable
diversity of methods which have been reported in recent years, including organometallic and organocata-
lytic processes.
1. Introduction
Optically active amines are essential functional groups in
many biological molecules. Hence, considerable amount of
efforts have been made to develop strategies to obtain these.
Imine reductions are some of the most fundamental trans-
formations in organic synthesis and are considered key reac-
tions in fine chemical and pharmaceutical industries for the
production of valuable amines. It is evident that a consider-
able amount of research has been done on reducing CvN
bonds enantioselectively using various strategies. These
include pressure hydrogenation using H2 gas, asymmetric
transfer hydrogenation (ATH) using organic molecules as the
reducing agent and organocatalytic reduction by using chiral
reagents and these are probably the most common methods
used to achieve reduction of imines to optically active chiral
amines. All of these are important methods as sometimes one
is preferred over the other depending on the situation. For
instance, although ATH is a convenient and versatile method
for imine reduction which avoids the use of a pressure reactor,
most industries often prefer to use pressure hydrogenation
over ATH since it utilises relatively inexpensive hydrogen gas
as a hydrogen source and is potentially 100% atom efficient.
Moreover, AH and ATH generally involve the use of a metal to
deliver a hydrogen from a respective source whereas organoca-
talytic reduction avoids metals and utilises a chiral organic
molecule to deliver the hydrogen to the imine.
This review aims to cover recent developments in the field
of imine reduction by using AH, ATH and organocatalytic
reductions. We will focus on the recent advancements in the
last five years including 2016, since earlier results are widely
reported by some recent reviews.1 This review primarily
focuses on recent reports on catalysts based on iridium, ruthe-
nium and rhodium, for AH and ATH for imines and sub-
sequently organocatalytic reduction using chiral phosphoric
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acid and borane are covered. This review does not include
non-asymmetric reports although interesting reports of the
use less widely used approaches or reagents have been pub-
lished in recent years.2
A striking aspect of the chemistry of imine reduction is the
diversity of methods which have been employed, including
metal-based and metal-free, and the use of a wide range of
reducing agents. In this review we have tried to capture the
remarkable range of exciting new synthetic chemistry method-
ology which has been developed during the course of these
internationally-ranging studies.
2. Asymmetric hydrogenation (AH) of
imines
2.1. Iridium-catalysed imine AH
A simple and efficient method for the synthesis of chiral ter-
tiary amines was developed by Zhou and co-workers. A chiral
iridium-diphosphine ligand catalyst was employed to produce
chiral N-alkyl tetrahydroisoquinolines and N-alkyl tetrahydro-
β-carbolines via asymmetric hydrogenation in up to 96% ee
and 88% ee, respectively (Fig. 1).3 The protocol gives access to
the synthesis of a class of drug molecule containing the
N-alkyl tetrahydroisoquinoline moiety in a single step which
does not need further alkylation to obtain the enantiomerically
enriched product.
Studies on the use of an Ir-catalyst with a diphosphine
ligand and I2 as additive in THF led to the AH of 4-phenylqui-
nazolin-2(1H)-one in 77% ee (Fig. 2). Better enantioselectivities
were obtained when the additives were changed to NIS (69%
ee), NBS (95% ee) or BCMDH (96% ee). Upon finding the best
additive, the diphosphine ligand was replaced with (R)-
SegPhos 1, increasing the ee to 97%. The developed catalytic
system was then applied to a library of substrates (Fig. 2). It
was found that there were no decreases in yields or ee when
either methyl or chloro groups were introduced to the fused-
aryl ring.4
A large amount of research has been conducted on the
reductions of 1-aryl-3,4-dihydroisoquinolines using iridium-
catalysed asymmetric hydrogenation. Chang and co-workers
have reported the synthesis of bioactive chiral-1-substituted
tetrahydroisoquinolines via a one pot N-deprotection and cata-
lytic intramolecular asymmetric reductive amination.5 In this
protocol, the iodine bridged dimeric [{Ir(H)[(R)-SegPhos]}2(µ-
I)3]
+I− complexes have been utilised in the presence of the
Lewis acid titanium(IV) isopropoxide, molecular iodine, and
p-toluenesulfonic acid as additives to activate the catalyst. This
particular catalysis system proved to be effective in producing
various enantiomerically pure tetrahydroisoquinoline alkaloids
including the pharmaceutical Solifenacin, in high ee (Fig. 3).
In another recent study on the AH of 1-aryl-3,4-dihydroiso-
quinolines, the Josiphos ligand 3 was shown, by Zhang et al. to
exhibit turnover numbers of up to 4000 and with excellent
enantioselectivities (up to 99% ee) in the AH of 1-phenyl-3,4-
dihydroisoquinoline. AH of a library of isoquinolines sub-
strates as depicted in Fig. 4, where R2 is a substituted aryl,
gave products in 85–99% ee. The addition of HBr was essential
for high reactivity and enantioselectivity in this reaction. The
procedure was also applied at the gram-scale hydrogenation to
yield the asymmetric precursor of Solifenacin.6
Schwenk and Togni reported the applications of P-chiral
diphosphine ligands containing a trifluoromethyl substituent
in the Ir(I)-catalysed asymmetric hydrogenation of dihydroiso-
quinoline hydrochlorides. The use of the hydrochlorides was
important for high selectivity, with products formed in up to
96% ee.7
A one-pot N-Boc deprotection/intramolecular asymmetric
reductive amination to synthesise chiral tetrahydroquinolines
and tetrahydroisoquinolines has been demonstrated. This
Brønsted acid protocol utilises Ir/ZhaoPhos catalytic system to
furnish wide range of chiral tetrahydroquinolines and tetrahy-
droisoquinolines in excellent ees (Fig. 5).8
After publishing a successful AH on cyclic imines with
Josiphos-type binaphane ligands, Zhang et al. applied the
same catalytic system to the AH of acyclic aromatic
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N-arylimines.9 A variety of acyclic imines were hydrogenated to
the corresponding optically active amines in good to excellent
ee. The utility of this protocol has been demonstrated by
synthesizing a key chiral intermediates to calcium sensing
receptor modulators on a gram scale (Fig. 6).
Johansson et al. investigated the asymmetric reduction of
α-arylfuryl-containing imines.10 Initial studies found the ATH
of α-phenylfuryl-containing imines with Noyori-type catalysts
gave the amine products in 60–74% ee. By contrast, pressure
hydrogenation using an Ir-based catalyst with a diphosphine
ligand, f-BINAPHANE 5, resulted in formation of the asym-
metric amine product in 82% ee. Upon finding the optimum
catalyst and conditions, a range of N-methyl imines with
varying groups on the aryl functionality were reduced with
Fig. 1 AH of N-alkyl tetrahydroisoquinolines and N-alkyl tetrahydro-β-carbolines.
Fig. 2 Iridium-catalysed AH of 4-phenylquinazolin-2(1H)-one.
Fig. 3 Reductions of 1-aryl-3,4-dihydroisoquinolines and enantioselective synthesis of Solifenacin.
Organic Chemistry Frontiers Review
This journal is © the Partner Organisations 2020 Org. Chem. Front.
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Fig. 4 AH of 1-aryl-3,4-dihydroisoquinolines by Ir-Josiphos 3 complex.
Fig. 5 Intramolecular asymmetric reductive amination.
Fig. 6 AH of acyclic aromatic N-arylimines and synthesis of optically active calcium sensing receptor modulators.
Review Organic Chemistry Frontiers
Org. Chem. Front. This journal is © the Partner Organisations 2020
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80–90% ee to the corresponding amine products (Fig. 7). A
separate study revealed that the N-alkylated group significantly
affects the ee of the product, where either distal branching or
longer-chained alkyl groups slightly decreased the enantio-
selectivity when compared to its N-methylated derivative.
However, the greatest effect on ee was with proximal branching
where an i-Pr chain gave the amine product in 34% ee. The
reduction products could potentially undergo oxidative clea-
vage of the furyl moiety to provide non-naturally occurring
amino acids.
In another application of BINAPHANE 5, Zhou et al. have
found a convenient method for the iridium-catalysed asym-
metric hydrogenation of 4,6-disubstituted 2-hydroxypyrimi-
dines in high ee (Fig. 8).11 Both electron-donating and elec-
tron-withdrawing groups could be tolerated on the substi-
tuted 2-hydroxypyrimidines, with the method giving products
in up 96% ee. In the reaction, the presence of TCCA was
suggested to favour the oxo form, from the lactam–lactim
tautomerism, of the 2-hydroxypyrimidines which in turn
facilitates the hydrogenation. Additionally the methodology
was applied to the more challenging trisubstituted pyrimi-
dines. Under the conditions, the substrates undergo partial
hydrogenation to give 3,4-dihydropyrimidin-2-(1H)-ones in up
to 83% ee.
Hou and co-workers have demonstrated an additive free
protocol for the synthesis of optically active cyclic amines.12
This methodology involves the use of an iridium precursor
with (R,R)-f-SpiroPhos ligand 6 as a catalyst-ligand combi-
nation to effect asymmetric hydrogenation of a variety of cyclic
2-aryl imines under mind conditions. Through this approach,
optically active free amines can be produced in high yields and
enantioselectivities (Fig. 9). This methodology was further
applied to the synthesis of biological active molecular skel-
eton, (+)-(6S,10bR)-McN-4612-Z.
Fig. 7 Asymmetric reduction of α-arylfuryl-containing imines and conversion into a chiral amino acid by oxidative cleavage.
Fig. 8 Iridium-catalysed asymmetric hydrogenation of 4,6-disubstituted 2-hydroxypyrimidines.
Organic Chemistry Frontiers Review
This journal is © the Partner Organisations 2020 Org. Chem. Front.
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Hou and co-workers also developed an additive free Ir-f-
SpiroPhos 6-catalysed reductive amination methodology to
obtain chiral cyclic amines. A variety of chiral cyclic amines
synthesised through intramolecular reductive amination of
N-Boc-protected amino ketones were formed in excellent
enantioselectivity (up to 97% ee).13 Further, the method was
applied in the synthesis κ-opioid receptor selective antagonist
(Fig. 10).
A one pot N-Boc deprotection and intramolecular hydroge-
native asymmetric reductive amination approach was devel-
oped to synthesise 2-substituted pyrrolidines. The current pro-
tocol utilises in situ generated Ir-chiral ferrocene ligand as
catalyst. A wide range of chiral pyrrolidines were prepared in
ee up to 92% (Fig. 11).14
He et al. found that diarylmethanimines could be asymme-
trically hydrogenated using the f-spirophos ligand 6 in an
iridium-catalysed reaction (Fig. 12).15 Excellent enantio-
selectivities were obtained when an ortho-substituted phenyl
was present. Substrates containing 2-Cl and 2-Br substituents
could also be dehalogenated after the asymmetric hydrogen-
ation to provide phenyl containing substrates without loss in
enantioselectivity. The method was applied at a gram scale
and was found to hydrogenate at a lower catalyst loading when
higher pressures were employed providing turnover numbers
up to 4000.
Quinoxaline-type compounds were reduced in iridium-cata-
lysed AH with ligand 8 however the catalytic system proved to
be reversible via a dehydrogenative rearomatization. Zhou
et al. found that the reversible reaction was prevented by
addition of Ac2O to afford the acetylated amine products
(Fig. 13). Further application of the catalyst system to a variety
of mono-substituted phenyl-quinoxaline substrates was under-
taken and, when R was aromatic, reductions were achieved in
95–97% ee. The catalysts saw a loss in enantioselectivity when
the R group was changed to an alkyl group, in which case, pro-
ducts of 37–87% ee were formed. Additionally, phenanthri-
dine-type substrates were found to be compatible and gave the
corresponding amine products in 62–98% ee.16
In a study by Verdaguer et al., four diastereomers of the
ligand in complex 9a were synthesised alongside their respect-
ive complexes. AH of acetophenone-N-methyl imines with the
complexes gave products in low enantioselectivities of 9–71%
Fig. 9 Additive free protocol for the synthesis of chiral cyclic amines.
Fig. 10 Intramolecular asymmetric reductive amination and application to a pharmaceutical target.
Review Organic Chemistry Frontiers
Org. Chem. Front. This journal is © the Partner Organisations 2020
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/1
0/
20
20
 1
:4
5:
58
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
ee.17 Later studies revealed that the addition of the additives
acetophenone-N-phenyl imine and THF yielded complex 9b
which in turn provided a greater enantioselectivity of 91% ee
for the reduction product of acetophenone-N-methyl imine.
Catalyst 9b was found to work effectively at low pressures; 3
bar of H2 gas, and low temperatures of −10–0 °C. A range of
imines were asymmetrically reduced as shown in the scheme
in Fig. 14, and the different substituents on the phenyl group
of the substrates were tolerated without major changes in ee.
Further applications demonstrated that different N-alkyl
groups were also compatible, without significant change in
product ee.
In a further application of 9a, the catalyst was found to be
effective in the AH of acetophenone N-aryl imines. A range of
substituents on the phenyl ring were found to be tolerable by
the catalysts with amines formed in 74–96% ee however a sub-
Fig. 11 Asymmetric synthesis of 2-substituted pyrrolidines.
Fig. 12 Asymmetric hydrogenation of diarylmethanimines.
Fig. 13 Iridium-catalysed AH of quinoxaline and phenanthridine.
Organic Chemistry Frontiers Review
This journal is © the Partner Organisations 2020 Org. Chem. Front.
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strate containing an ortho substituent was reduced in just 28%
ee (Fig. 15).18
Recent advances by Zhang include the use of the
N-methyated ligand 10 where the parent ligand has pre-
viously been reported as an effective ligand for Pd-based
hydrogenations.19 Zhang’s unmethylated derivative was
unsuccessful in AH with [Ir(COD)Cl2] however the methylated
derivative 10 formed effective catalysts in the AH of imines
of the type shown in Fig. 16. A range of substituted phenyl
(R = Ar) derivatives of these imines were reduced in 92–99%
ee with naphthalene and thiophene derivatives also reduced
in 97% and 96% ee respectively. The aromatic moieties in
the substrates proved to be crucial when using the catalytic
system; a benzyl derivative gave a lower enantioselectivity of
73%.
A wide range of chiral N,N′-diaryl vicinal diamines have
been synthesised by Fan and co-workers.20 This ruthenium or
iridium-catalysed protocol follows intermolecular reductive
amination/asymmetric hydrogenation with a 2-quinoline alde-
hyde and aryl amines. The optically active chiral diamine
could be obtained in excellent enantioselectivities and were
subsequently easily converted into sterically hindered
N-heterocyclic carbenes. The iridium complex 11 was found to
be effective for the synthesis of non hindered chiral vicinal dia-
mines with high enantioselectivities whereas the ruthenium-
catalysed complex 12 was found suitable for the synthesis of
hindered vicinal chiral diamines (Fig. 17). Furthermore, the
utility of the process was demonstrated by applying the opti-
cally active chiral diamine in an asymmetric palladium-cata-
lysed Suzuki–Miyaura cross-coupling reaction.
Fig. 14 Iridium catalysed AH of acetophenone-N-alkyl imines.
Fig. 15 Ir-Catalysed AH using catalyst 9a.
Fig. 16 AH of cyclic sulfamidate imines.
Review Organic Chemistry Frontiers
Org. Chem. Front. This journal is © the Partner Organisations 2020
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/1
0/
20
20
 1
:4
5:
58
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
A facile and efficient approach to the hydrogenation of 2,4-
diaryl-3H-benzo[b]azepines has been developed by Fan and co-
workers.21 Dendritic phosphinooxazoline iridium complexes
have been applied to synthesise optically active 2,4-diaryl-2,3-
dihydro-1H-benzo[b]azepine derivatives (Fig. 18). This chemo-
selective and enantioselective approach converts the imine
into the corresponding product in full conversions with good
to excellent enantioselectivities without affecting the CvC
bond in the structure.
An additional study into CvN reductions has been carried
out using DFT calculations to investigate the mechanism of
hydrogenation for the catalyst system shown in Fig. 19. The
results suggest that the iridium catalysed reaction proceeds
through an outer-sphere pathway.22
Yang et al. have applied a similar approach of N-Boc de-
protection/intramolecular asymmetric reductive amination to
synthesise bridged biaryl derivatives (Fig. 20).23 The Ir-cata-
lysed protocol furnishes synthetically important dibenz[c,e]aze-
pines containing both centre and axial chiralities in excellent
enantioselectivities (up to 97% ee). A variety of chiral dibenz[c,
e]azepines have been obtained through this methodology uti-
lising (S)-DifuorPhos and (S)-SegPhos ligands. The application
of the methodology has been shown by synthesizing an ana-
logue of allocolchicine using the ZhaoPhos ligand (Fig. 20).
Chang and co-workers developed a highly efficient and
novel approach to tertiary chiral amines via direct catalytic
asymmetric reductive amination.24 In this protocol, secondary
amines undergo direct reductive amination with ketones cata-
lysed by Ir-phosphoramidite ligand complexes. Rivastigmine,
which is used in the treatment of Alzheimer’s and Parkinson’s
type diseases, was synthesised by this facile and scalable
method (Fig. 21).
1-Alkyl dihydroisoquinolines have been successfully hydro-
genated in high ee using Ir(I) complexes containing chiral
spiro iridium phosphoramidite ligands. Two equivalents of the
ligands were required, relative to Ir(I).25 Ir(I) complexes con-
Fig. 17 Synthesis of chiral N,N’-diaryl vicinal diamines by AH and application of the diamine product in Suzuki coupling.
Fig. 18 Chemoselective and enantioselective AH of 2,4-diaryl-3H-benzo[b]azepines.
Organic Chemistry Frontiers Review
This journal is © the Partner Organisations 2020 Org. Chem. Front.
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/1
0/
20
20
 1
:4
5:
58
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
taining an (R)-synphos ligand were employed in a redox
deracemisation of a range of amines, including tetrahydroiso-
quinolines, in up to 98% ee. In this process, NBS was used
as an oxidant to create an imine intermediate in the
reaction.26
2.2. Rhodium-catalysed imine AH
In a Rh-catalysed AH, a dibenzo[b,e]azepine substrate was
reduced in up to 96% ee using ligand 15 (Fig. 22), whereas
other ligands were less effective, e.g. SegPhos and JosiPhos
which delivered products of 40% and 60% ee respectively.
Zhang proposed that the thiourea moiety in ligand 15 activates
the substrate via an anion-bonding interaction.27 The catalyst
system was then applied to a range of substrates and it was
found that when R3 was a methyl, all substrates were reduced
with excellent enantioselectivities of 92–99% irrespective of
the groups on R1 and R2. However, an ethyl group (R3 = Et)
proved to be a poorer substrate with only a 71% ee achieved
for the reduced amine product. Further application of the cata-
lyst system using a gram-scale of substrate also proved
effective.
Rhodium-catalysed asymmetric hydrogenations of substi-
tuted 1,5-benzodiazepinones has been achieved by Rueping
and co-workers (Fig. 23). The basis of the success in this proto-
col lies in the fruitful combination of the weakly coordinating
tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate (BArF) anion
and ligand 16 in the rhodium-catalyzed hydrogenation thereby
producing the optically active pharmacologically relevant class
of dihydro-1,5-benzodiazepines in high yields and ee (up to
92% ee).28
Zhang has developed a rhodium-based protocol for asym-
metric hydrogenation of alkynyl-aryl hydrazones. A rhodium
complex [Rh((R,Sp)-JosiPhos)(cod)]SbF6 allows access to a
chemoselective and enantioselective approach to optically
active propargyl hydrazines in good conversion and excellent
ee (Fig. 24).29 A variety of substrates containing triple bonds
were converted to chiral amines without affecting the alkyne.
Furthermore, this protocol gives easy access to chemically
important structure motifs, i.e. chiral propargylamines, from
chiral propargyl hydrazines.
Fig. 19 Iridium precatalyst with phosphine-oxazoline ligand for AH of N-alkylated imines.
Fig. 20 Synthesis of dibenz[c,e]azepines containing both centre and
axial chirality.
Fig. 21 Tertiary amine synthesis via intermolecular reductive amination
catalysed by Ir-phosphoramidite complexes.
Review Organic Chemistry Frontiers
Org. Chem. Front. This journal is © the Partner Organisations 2020
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2.3. Ruthenium-catalysed imine AH
Kačer et al. have developed a method to asymmetrically hydro-
genate dihydroisoquinolines and β-carboline-type compounds
Fig. 25.30 The method was found to be compatible with a total
of eight Ru and Rh half-sandwich complexes where trifluoroa-
cetic acid is employed for substrate activation. In a separate
study, catalysts 18a, b and c were found to reduce the dihydroi-
soquinolines and β-carboline-type compounds asymmetrically
in a transfer hydrogenation reaction using formic acid–triethyl-
amine. A kinetic study comparing the ATH reaction with cata-
lysts 18a, b and c showed that the hydroxybutyl catalyst 18b,
reduced imines most rapidly, followed by 18c then 18a, all of
which gave similar enantioselectivities.
Biologically important pharmacophores such as benzoaze-
pines, benzodiazepines, and benzodiazepinones have been
synthesised by cationic ruthenium–diamine catalysts 18d/18e.
This class of seven-membered N-containing heterocyclic
imines have been hydrogenated in up to 99% ee (Fig. 26). The
stereochemical outcome in this study was governed by the
Fig. 22 Rhodium catalysed AH of dibenzo[b,e]azepine and gram scale reduction.
Fig. 23 AH of substituted 1,5-benzodiazepinones.
Fig. 24 Chemoselective and enantioselective synthesis of chiral propargyl hydrazines.
Organic Chemistry Frontiers Review
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counter anion of the cationic complex, and complete reversal
of enantioselectivity was observed when ruthenium catalyst (R,
R)-18e bearing a phosphate anion was employed. Hence, all of
these imines could be converted to both product enantiomers
simply by changing the counteranion with the same configur-
ation of ligand.31
The construction of julolidine derivatives was achieved by a
ruthenium-catalysed cascade double reduction strategy. This
ruthenium-catalysed protocol proceeds via enantioselective
hydrogenation followed by reductive amination of 2-(quinolin-
8-yl)ethyl ketones which are converted into optically active
julolidines. The chiral product being obtained in excellent dia-
stereo- and enantioselectivity. Furthermore, the methodology
was applied to the preparation of the new chiral fluorescent
molecular rotor (Fig. 27).32
Chiral cationic ruthenium complexes have been applied to
the AH of bis(quinolin-2-yl)methanes to synthesise optically
active 1,3-diamines.33 The corresponding chiral bis(tetrahydro-
quinolin-2-yl)methanes were obtained in excellent diastereo-
and enantioselectivity (Fig. 28). The given protocol gives easy
access to 6-membered chiral NHC ligands from optically active
1,3-diamines which otherwise difficult to prepare by any other
route.
A novel method to obtain optically pure chiral endocyclic
vicinal diamines have been demonstrated by Fan and co-
workers.34 In this protocol, the chiral cationic ruthenium
diamine catalyst 19 has been applied to the AH of 2,2′-bisqui-
noline and 2,2′-bisquinoxaline derivatives to give the corres-
ponding chiral amines in good diastereoselectivity (up to
93 : 7) and excellent enantioselectivity (>99% ee) (Fig. 29).
These chiral diamines provided an easy access to chiral
N-heterocyclic carbenes which would otherwise be difficult to
prepare by another route.
Fig. 25 Ru-Catalysed hydrogenate dihydroisoquinolines and β-carboline hydrogenation.
Fig. 26 AH of seven-membered N-containing heterocyclic imines.
Fig. 27 AH of 2-(quinolin-8-yl)ethyl ketones and conversion of product into a chiral fluorescent molecular rotor.
Review Organic Chemistry Frontiers
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The effect of solvents such as oligo(ethylene glycols) (OEGs)
and poly(ethylene glycols) (PEGs) has been studied for asym-
metric hydrogenation of quinoline derivatives using chiral cat-
ionic ruthenium complexes. The hydrogenation failed in PEG
or long chain OEG, whereas 2-substituted quinoline derivatives
were easily reduced in short chain OEG, providing the
corresponding products in excellent enantioselectivities
(Fig. 30).35
A range of seven-membered cyclic imines was reduced by
cationic ruthenium diamine catalysts. The counter anion of
the ruthenium catalyst played a major role in the chiral induc-
tion and dibenzo[c,e]azepines were reduced in moderate to
excellent ees (Fig. 31). The corresponding optically active
amine product was obtained in up to 96% ee. Biologically
important chiral 6,7-dihydro-5H-dibenz[c,e]azepines were syn-
thesised in one step through a reductive amination/asym-
metric hydrogenation strategy by applying this method.36 Fan
et al. have also, in earlier research, reported highly enantio-
selective AH of both dihydro isoquinolines and quinolines to
form chiral tetrahydroquinolines and tetrahydroisoquinolines
respectively, using Ru(II) Noyori catalysts in ionic liquids.37
Fan et al. have also applied ruthenium catalysts to cascade
reductive amination/asymmetric hydrogenation of range of
quinolinyl, indolinyl and quinoxalinyl-containing ketones.
This highly efficient protocol converts ketones into optically
active products with excellent diastereo- and enantioselectivity.
The counter anion of the catalyst plays a crucial role hence a
diverse range of ruthenium complexes have been applied to
this transformation and a particular type of ruthenium
complex was found suitable for each class of substrates
(Fig. 32). The applicability of this methodology has demon-
strated by the formal synthesis of (+)-gephyrotoxin.38
Fan and co-workers have also developed a one-pot method-
ology to construct enantiomerically-pure benzo-fused
Fig. 28 AH of bis(quinolin-2yl)methanes and subsequent conversion into chiral NHC ligand.
Fig. 29 AH of 2,2’-bisquinoline and 2,2’-bisquinoxaline derivatives.
Organic Chemistry Frontiers Review
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N-heterocycles via sequential intramolecular hydroamination
and asymmetric hydrogenation.39 This ruthenium catalysed
protocol furnishes optically active 1,2,3,4-tetrahydroquinoline,
indoline, and 2,3,4,5-tetrahydro-1H-benzo[b]-azepine deriva-
tives in moderate to excellent ee. 2-Alkyl-1,2,3,4-tetrahydroqui-
nolines derivatives were obtained in high ee with chiral ruthe-
nium catalyst alone, whereas 2-phenyl 1,2,3,4-tetrahydroquino-
line and indoline derivatives were obtained in high ee using a
binary system consisting of an achiral gold complex and chiral
ruthenium complex (Fig. 33). The utility of this methodology
have shown by synthesizing the tetrahydroquinoline alkaloid
(−)-Angustureine.
Optically active 5,6-dihydrophenanthridines have been pre-
pared by using the chiral cationic ruthenium complex 25. In
this methodology, the selection of counter anion again proved
crucial in order to achieve high enantioselectivities (Fig. 34). A
wide product range was generated, providing corresponding
amines in the range of 75–92% ee.40
A class of biologically and pharmaceutically important sub-
structures have been synthesised by ruthenium-catalysed
enantioselective hydrogenation. Optically enriched 1,2,3,4-tet-
rahydro-1,8-naphthyridines have been prepared by using chiral
cationic ruthenium complexes (Fig. 35). A wide range of sub-
strates were converted into the products in ees up to 99%.
Furthermore, chiral products prepared by this method have a
potential to develop into modular P–N ligands.41
Zhang and co-workers developed direct reductive amination
approach to obtain chiral primary amines. A new system
identified, where ruthenium C3-TunePhos catalytic system was
utilised to affect the following transformation, which makes
use of ammonium acetate as the amine source and H2 as the
hydrogen source (Fig. 36).42 A wide range of substrates was
screened, containing a diverse array of tolerable functional
groups and chiral primary amines were obtained in up to 98%
ee. Further, the utility of the current protocol was demon-
strated by synthesizing a drug intermediate, tecalcet hydro-
chloride, on a gram scale.
2.4. Other metal-catalysed imine AH
Zhang et al. have screened a diverse range of phosphine-based
ligands able to form active nickel catalysts in the AH of
Fig. 30 AH of substituted quinoline in short chain OEG.
Fig. 31 AH of seven-membered cyclic imines derivatives and one step synthesis of chiral 6,7-dihydro-5H-dibenz[c,e]azepines.
Review Organic Chemistry Frontiers
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N-sulfonyl imines.43 Exhibiting one of the highest catalytic
activities and an ee of 97% was the complex of the (R,R)-
QuinoxP* ligand 27 (Fig. 37) in the reduction of 2-methyl-N-(1-
phenylethylide-ne)propane-2-sulfonamides. Exploring the sub-
strate scope; ortho-substitution of the aromatic ring with either
electron-donating or electron-withdrawing groups gave pro-
ducts in 97–99% ee. On the other hand, meta-substituted sub-
strates proved challenging with substrates containing electron-
Fig. 32 Ruthenium catalysed cascade reductive amination/asymmetric hydrogenation of range of quinolinyl, indolinyl and quinoxalinyl-containing
ketones.
Fig. 33 One-pot protocol to construct chiral benzo-fused N-heterocycles via sequential intramolecular hydroamination and asymmetric
hydrogenation.
Organic Chemistry Frontiers Review
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withdrawing groups affording lower yields and lower ees of
86–89%. Similar results were also exhibited by the para-substi-
tuted substrates. Changing the alkyl group in the substrate to
an ethyl or i-propyl group gave products in lower enantio-
selectivities of 80% and 78% respectively and the use of
fused cyclic rings provided the asymmetric products with
92–97% ee.
Zhang et al. have also investigated nickel-catalysed asym-
metric hydrogenations with the employment of a range of
chiral diphosphane ligands. Cyclic sulfamidate imines could
be reduced asymmetrically with a nickel/Ph-BPE complex
(Fig. 38). Initial studies with a range of chiral diphosphane
ligands revealed BINAP and SegPhos ligands to be ineffective
in the nickel-catalysed hydrogenation however the use of Ph-
PBE 28 proved effective in the AH of the phenyl-cyclic sulfami-
date imine, giving products in up to 92% ee. Focusing on the
substrate scope it was found that substituted phenyl groups
affords improved results in some cases and enantioselectivities
of 83–99%.44
Diphosphine ligand 2 was also found to be effective in the
Pd-catalysed AH of sulfonyl imines. The system proved
effective under a low hydrogen pressure and in the presence of
Lewis acids. AH of imines presented in Fig. 39 gave products
in 95–99% ee however the catalyst system was less enantio-
selective for non-activated imines, which gave products of
0–75% ee. The procedure was further applied to cyclic sulfonyl
imines that provided good enantioselectivity (59–90% ee) in
the reductions.45
The iron catalyst 29 was employed in the diastereo-
selective hydrogenation of N-alkylated chiral imines.46
Reduction of a phenyl derivative of the imine with the cata-
lyst system yielded the amine product in 96% yield and
Fig. 34 Ruthenium catalyzed asymmetric reduction of phenanthridine derivatives.
Fig. 35 Ruthenium catalyzed asymmetric reduction of phenanthridine derivatives.
Review Organic Chemistry Frontiers
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93 : 7 dr. Electron-donating substituents on the phenyl
groups (electron-rich imines) made ideal substrates with the
catalyst system giving products of up to 98 : 2 dr. On the
other hand, electron-poor imines gave products in lower
enantioselectivity, e.g. with an imine containing a para-tri-
fluoromethyl group giving a dr of 67 : 33. DFT calculations
on the reaction mechanism showed there to be a lower
energy in the transition state for hydrogenation of the Re-
face as shown in Fig. 40 compared to the Si-face. Proving
that most likely a concerted hydride transfer occurs through
the Re-face of the imines.
Morris and co-workers have investigated the ability of the
unsymmetrical iron P-NH-P′ catalyst 30 in the asymmetric
hydrogenation of activated imines. The base–metal precatalyst
has been found to reduce a diverse range of N-phosphinoyl
and N-tosyl aryl amines in good to excellent ee (Fig. 41). A DFT
study showed that the role of the oxygen atom of the substitu-
ent on the activated imine nitrogen is significant and makes a
hydrogen bond with the N–H of the iron catalyst.47
An iron-based ferrocene phosphonium/hydridoborate cata-
lyst 31, was developed using Piers’ borane [HB(C6F5)2] followed
by H2 splitting. The obtained frustrated Lewis acid catalyst was
applied to the asymmetric hydrogenation of various imines to
generate chiral amines in moderate to good ee (Fig. 42).48
Zhou et al. have demonstrated a rare application of palla-
dium metal in the asymmetric hydrogenation of imines.49
Even though significant research has been conducted on the
synthesis of chiral cyclic ureas using a multicomponent strat-
egy, this asymmetric hydrogenation protocol benefits from
direct access to chiral cyclic ureas. Following this protocol,
Fig. 36 Asymmetric primary amine synthesis via reductive amination.
Fig. 37 Nickel catalysed AH of N-sulfonylimines.
Fig. 38 Nickel catalysed AH of cyclic sulfamidate imines.
Organic Chemistry Frontiers Review
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asymmetric hydrogenation of 2-hydroxypyrimidine was
achieved to furnish optically active chiral cyclic ureas in up to
99% ee (Fig. 43). A wide substrate scope has been demon-
stated, including mono- and disubstituted 2-hydroxypyrimi-
dines. Furthermore, the chiral cyclic ureas can be converted to
1,3-diamines by hydrolysing the urea.
Fig. 39 Palladium catalysed AH of sulfonylimines.
Fig. 40 Iron catalysed diastereoselective hydrogenation of N-alkylated chiral imines.
Fig. 41 Iron catalysed AH of activated imines.
Review Organic Chemistry Frontiers
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3. Asymmetric transfer
hydrogenation (ATH) of imines
3.1. Iridium-catalysed imine ATH
A very recent and detailed study of the ATH of CvN bonds in
dihydroisoquinolines using chiral Cp*Ir(III) complexes revealed
remarkably complex behaviour, including the observation of
different kinetic orders of formation for each enantiomeric
product.50 The investigators were also able to conclude, from a
very careful series of studies, that the iminium cation was the
reduction substrate rather than the free imine. An IrCp* based
hybrid catalyst of 33 was prepared using the chiral structure of
the antibiotic vancomycin. The novel vancomycin–iridium(III)
interaction was proved by using techniques such as
MALDI-TOF, UV, circular dichroism (CD), Raman IR, and
NMR. The hybrid complex was further applied to the ATH of
various cyclic amines in aqueous media under mild reaction
conditions which furnished the corresponding cyclic amines
in good to moderate ee in the respective buffer solutions
(Fig. 44).51 Quinaldine was reduced in a MES (2-(4-morpho-
lino)ethanesulfonic acid) 1.2 M buffer at pH 5 with a impress-
ing 61% ee, whereas inversion of configuration was observed
in the case of 3-methylbenzo[d]isothiazole 1,1-dioxide where a
product of 42% ee was observed in phosphate buffer 0.1 M pH
8.
Gong et al. studied N-heterocyclic carbene-iridum catalysts
to reveal that catalyst 34 exhibited metal-centred chirality that
could be exploited in asymmetric reactions.52 Using catalyst 34
in an ATH reaction with ammonium formate as the hydrogen
source facilitated reduction of a cyclic N-sulfonylimine in 99%
ee. Under sodium formate or formic acid/triethylamine con-
ditions, the reactions both proceeded slower and it was ration-
alised that the ammonium ion was crucial in the reaction.
Fig. 42 Iron catalysed AH of N-alkylated imines.
Fig. 43 Palladium catalysed AH of mono- and disubstituted 2-hydroxypyrimidines.
Organic Chemistry Frontiers Review
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Applying the catalyst system to a range of cyclic N-sulfonylimines,
as in Fig. 45, the ATH of these revealed that in cases where R1 was
a phenyl group and R2 a substituted-phenyl group, the catalyst
system gave products in 96 to 98% ee. Also when R2 was a methyl
and R1 were aryl groups, the products were obtained in 94 to 98%
ee. The same trends were also seen with a range of alkyl groups at
the R2 position. With the results in hand, the method was
applied to a half-gram scale of a bioactive compound with anti-
HIV activity in 97% ee.
Rimoldi and co-workers have completed an interesting
comparison of AH and ATH for the iridium-catalysed reduction
of various imine derivatives (Fig. 46).53 This approach makes
use of atropoisomeric diphosphines and cyclic diamines as
ligands for AH and ATH respectively. Four challenging classes
of cyclic imine substrates were selected and studied under
optimised reaction conditions using both the protocols. ATH
proved to be a superior method for the synthesis of optically
active cyclic amines with 3,4 dihydroquinolines and sulfonyl
amines being formed in up to 86% ee whereas AH was found
to be a method of choice in the case of isoquinolines and qui-
nolines which gave chiral amines in ee up to 64% ee.
Catalyst 37 was found to reduce 1-phenyl-3,4-dihydroisoqui-
noline in 83% conversion and 63% ee whereas the rhodium
analogue under the same conditions carried out the ATH in
66% conversion and just 3% ee. With the results in hand,
Červený and co-workers explored the addition of Lewis and
Brønsted acids to the Ir-catalysed system and found that the
addition of anhydrous phosphoric acid (APA) increased both
conversion and enantioselectivity to 99% and 86% respect-
ively.54 The substrate scope of catalyst 37 was expanded to sub-
strates of the type shown in Fig. 47 with varying substituted-
phenyl groups giving rise to products of 64–86% ee. Applying
the methodology however to a dihydro-β-carboline derivative
was less effective; providing the reduced product in just 50%
ee.
Zhao et al. have developed a highly enantioselective method
for the ATH of N-aryl and N-alkyl ketamines (Fig. 48).55 The
iridium catalyst 38a aided by a chiral phosphoric acid ligand
38b catalyses the ATH of ketimines using an alcohol as the
hydrogen source. The diol was found to provide the highest
enantioselectivity from a series of alcohols, as hydrogen
sources, with DFT studies providing evidence for the formation
of an iridium alkoxide as the reducing agent. High enantio-
selectivities were obtained when R1 was alkyl or aryl and the
N-group was either alkyl or aryl.
Over an extended period of intense investigations, Ward
et al. have completed the highly successful optimisation of an
Ir(III)-based catalyst system in which the environment of the
protein streptavidin serves to direct the asymmetric transfer
hydrogenation in an aqueous environment. Selective modifi-
cation of the streptavidin structure permits fine-tuning of the
resulting new synthetic metalloenzymes towards their sub-
strates, and notably tetrahydroisoquinolines in particular.56
Fig. 44 ATH of substituted amines using vancomycin as a chiral ligand.
Fig. 45 ATH of cyclic N-sulfonylimines.
Review Organic Chemistry Frontiers
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3.2. Rhodium-catalysed imine ATH
DKR-ATH of 5-alkyl cyclic sulfamidate imines have been
reported by Lee and co-workers. This DBU promoted protocol
utilises a Noyori-type chiral rhodium catalyst and HCOOH/
DBU as a hydrogen source.57 This particular process takes
place through DBU promoted rapid racemisation of the cyclic
imine substrates. Through this methodology a wide range of
sulfamidates have been prepared in excellent diastereo- and
enantioselectivities (Fig. 49).
A detailed computational study of the mechanism of trans-
fer hydrogenation by Cp*Rh(III) complexes has been reported,
revealing the importance of different substituents on the che-
lating ligand for optimal efficiency.58
3.3. Ruthenium-catalysed imine ATH
An efficient methodology to synthesise optically active allylic
amines has been demonstrated by Guijarro and co-workers.
This protocol involves distereoselective transfer hydrogenation
Fig. 46 Comparison of AH and ATH for the iridium-catalysed enantioselective reductions of various imine derivatives.
Fig. 47 ATH of 1-phenyl-3,4-dihydroisoquinoline derivatives.
Fig. 48 ATH of N-aryl and N-alkyl ketamines.
Organic Chemistry Frontiers Review
This journal is © the Partner Organisations 2020 Org. Chem. Front.
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/1
0/
20
20
 1
:4
5:
58
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
of enantiomerically-pure α,β-unsaturated N-(tert-butylsulfinyl)
ketimines which were then converted to allyl amines by
removal of the sulfinyl group. Through this methodology, the
enantiomer of interest can be synthesised in 97 to 99% ee
simply by selecting the sulfinyl group with the appropriate
absolute configuration (Fig. 50).59
Noyori’s complex 18a was applied to the ATH of derivative
of imines in the total synthesis of a range of dysoxylum alka-
loids. The all-important stereogenic centre in both enantio-
meric forms were obtained at by reducing the CvN bond
(Fig. 54). Ruthenium catalysed asymmetric induction was
affected by using sodium formate as a hydrogen source and
the dysoxylum alkaloids were obtained in ees of up to 97%
after methylation at the nitrogen. With the results at hand the
mechanism was proposed to occur via the substrate approach-
ing the catalyst through an N+–H⋯OvS interaction between
the protonated imine and the oxygen on the sulfonyl group of
the catalyst which is then further aided by a CH⋯π interaction
as shown in Fig. 51.60
The particular role of the η6-arene ligand in the ATH of
dihydroisoquinolines has previously been the subject of
detailed investigations.61 The effect of the level of electron-
richness of the substituents on the fused aromatic ring of
dihydroisoquinolines on rates of reduction by Noyori catalysts,
studied by 1H NMR spectroscopy has also been studied in
depth.62
Several papers have been published in the last decade
describing the use of Ru(II) Noyori catalysts for the ATH of
1-aryl dihydroisoquinolines which, in contrast to 1-alkyl
derivatives, are regarded as quite challenging substrates.
Generally, either an ortho-substituent is required to be
present on the 1-aryl ring of the DHIQ for best results, or the
fused ring must be electron-rich.63 A recent solution to the
challenge presented by DHIQs lacking both requirements was
achieved b the addition of a methylfuran group to the basic N
atom of the TsDPEN.64 Novel derivatives of the C2-symmetric
diamine used in arene/Ru(II) ATH catalysts continue to be
developed, including a series of recently reported, pyridinium-
containing examples which facilitate ATH in aqueous
solution.65
A further application of catalyst 18a in ATH was studied on
dibenzo[b,f ][1,4]oxazepines substrates by Bhanage and More.66
Preliminary studies revealed the catalyst system to be depen-
dent on the pH of the reaction, in cases where the pH was
greater than 5 the conversion decreased drastically and it was
found that at pH 4 the conversion reached 99% and afforded
the reduced product in 93% ee. The substrate scope was
expanded with R1 as a methyl group that allowed the reduction
of the mono substituted R4 group to yield products of 80–91%
ee. Groups on R2 gave products of 71–93% ee and di-substi-
tuted aryl rings gave products of 77–91% ee. Substrates with R1
as an ethyl in turn produced products of 80–82% ee whilst a
substrate with a phenyl group gave a product of 80% ee
(Fig. 52).
A ruthenium catalysed chemo- and stereoselective synthesis
of Δ4-isoxazolines have been demonstrated by Wills and
Chew.67 This challenging class of cyclic amines have been pre-
pared using a mild reaction protocol and no side reaction
owing to ring opening was observed. The protocol makes use
of tethered ruthenium MsDPEN as a catalyst using HCOOH/
Fig. 49 DKR-ATH of 5-alkyl cyclic sulfamidate imines.
Fig. 50 Distereoselective transfer hydrogenation of enantiomerically-pure α,β-unsaturated N-(tert-butylsulfinyl) ketimines.
Review Organic Chemistry Frontiers
Org. Chem. Front. This journal is © the Partner Organisations 2020
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
Se
pt
em
be
r 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/1
0/
20
20
 1
:4
5:
58
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
TEA as a hydrogen source which gave the corresponding pro-
ducts in good to moderate ee (Fig. 53).
A new method of obtaining N,N-diamine ligands derived
from a natural source ((−)-menthol) was investigated by
Czarnocki et al. A newly formed ligand proved to act as chiral
ligand in a ruthenium catalysed asymmetric transfer hydrogen-
ation of the a range of ketone and endocyclic imine substrates
e.g. 1-methyl-3,4-dihydro-b-carboline, which were subsequently
converted to amines with excellent conversion and 72% ee
Fig. 54.68
3.4. Other metal-catalysed ATH
Fan et al. have used a variety of alcohols as a hydrogen source
in the asymmetric transfer hydrogenation of N-sulfonylimines
(Fig. 55).69 This palladium/zinc co-catalyst protocol required
screening of wide range of primary and secondary alcohols as
Fig. 51 ATH of dysoxylum alkaloids and a possible transition state.
Fig. 52 ATH of dibenzo[b,f ][1,4]oxazepines derivatives.
Fig. 53 ATH of isoxazolium Salts.
Organic Chemistry Frontiers Review
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a hydrogen donor out of which MeOH was found to be the
best. In this methodology, a Pd-hydride intermediate reduces
N-sulfonylimines to the corresponding optically active amines
in high ee.
4. Organocatalysed asymmetric
imine reductions
The chiral alkene 43 reacted with a boron species to form a
chiral boron-based Lewis acid able to catalyse the asymmetric
hydrogenation of imines as illustrated in Fig. 56. Employment
of the chiral boron species at 10 mol% could asymmetrically
reduce imine substrates in 45–89% ee.70
A frustrated Lewis pair of Piers’ borane and (S)-tertbutyl-
sulfinamide 44 has been applied to the ATH of the 2,3-di-
substituted quinoxalines by Du and co-workers.71 Utilising
ammonia borane as a hydrogen source this chiral Lewis acid
pair reduced a variety of 2,3-disubstituted quinoxalines
(Fig. 57). Interestingly, 2-alkyl-3-arylquinoxalines derivatives
solely gave the cis products in up to 86% ee, whereas 2,3-dia-
lkylquinoxalines often furnished trans products with ees of up
to >99%.
In a further application, the catalytic system using 44 was
applied to the ATH of β-N-substituted enamino esters.
Utilising ammonia borane as a hydrogen source, this chiral
Lewis acid pair reduced a variety of β-N-substituted enamino
esters in up to 91% ee. Further, the product was subjected to
cyclisation to furnish the optically active β-lactam which pro-
duced >99% ee after recrystallization with hexane (Fig. 58).72
A newly designed chiral ammonia borane catalyst was syn-
thesised by Du and co-workers and applied to the ATH of
imines and β-enamino esters (Fig. 59).73 This protocol works
through the dehydrogenation of the ammonia borane by the
chiral phosphoric acid 45 which acts as a Brønsted acid. The
chiral ammonia borane complex of 45 can be regenerated
through the addition of ammonia borane and water which
allows the use of the relatively more expensive CPA at very low
loading i.e. 0.1%. The hydrogen transfer in this reaction from
chiral borane to imine works through a 6-membered transition
state which gave optically active imines in moderate to excel-
lent ee.
Fig. 54 Application of a derivative of (−)-menthol in ruthenium catalysed ATH of 1-methyl-3,4-dihydro-β-carboline.
Fig. 55 Palladium catalysed ATH of N-sulfonylimines derivatives.
Fig. 56 Chiral alkene borane catalysed AH of N-alkylated imines.
Review Organic Chemistry Frontiers
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Another application of a chiral Brønsted acid for the ATH
of indoles proceeding through an iminium ion intermediate
has been reported (Fig. 60). A wide range of functional
groups are tolerated by this in situ generated chiral phospho-
ric acid borane catalyst to obtain chiral indolines in the
range of 64–96% ee. Theoretical studies support protonation
at the C3 carbon followed by asymmetric transfer
hydrogenation.74
Fig. 57 ATH of the 2,3-disubstituted quinoxalines using a frustrated Lewis pair of Piers’ borane and (S)-tertbutylsulfinamide.
Fig. 58 CPA catalysed ATH of β-N-substituted enamino esters and construction of chiral β-lactam.
Fig. 59 CPA catalysed ATH of N-alkylated imines.
Organic Chemistry Frontiers Review
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Peng and Akiyama have achieved a chiral phosphoric acid-
catalysed asymmetric reduction of fluorinated alkynyl keti-
mines.75 The mild reaction conditions allow a chemoselective
reaction, resulting in reduction of only the imine bond
without affecting the triple bond. The chiral phosphoric acid
catalysed approach involves a benzothiazole derivative as a
hydrogen source and produces optically active fluorinated
propargylamines in excellent ee (Fig. 61). Furthermore, the
obtained optically active fluorinated propargylamines have
been transformed into biologically active 2-(trifluoromethyl)-
1,2-dihydroquinolines with selective COX-2 inhibitory activity.
Speed et al. have synthesised a newly designed diazaphosphe-
nium triflate catalyst 48 and applied it to the synthesis of chiral
cyclic amines. A phosphenium cation-catalysed reaction proceeds
through hydroboration or hydrosilylation of cyclic imines which
gave the corresponding optically active heteroaryl pyrrolidines
and piperidines in up to 94% ee at as low as 0.2% catalyst
loading. This organocatalytic process tolerates imine substrates
with thiophenes or pyridyl rings which in some cases are one of
the limitations of metal catalysed ATH (Fig. 62).76
Wang et al. have enantioselectively hydrogenated 2-substi-
tuted quinoline-type compounds using newly developed chiral
Fig. 60 CPA catalysed ATH of indole derivatives.
Fig. 61 CPA catalysed asymmetric reductions of fluorinated alkynyl ketimines and conversion of product into 2-(trifluoromethyl)-1,2-
dihydroquinoline.
Fig. 62 Phosphenium cation-catalysed ATH of cyclic imines.
Review Organic Chemistry Frontiers
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bicyclic bisborane catalysts.77 The borane 49 was employed in
the hydrogenation of quinolines bearing an alkyl substituent
(R2 = alkyl), Fig. 63, giving products with high enantio-
selectivity. The method was found to also tolerate both conju-
gated and unconjugated olefins, alkynes and consecutive
double and triple bond substituents at R2. For 2-substituted
quinolines with aryl groups, Borane 50 was found to give pro-
ducts in up to 93% ee. The reaction system in this case is
assisted by the addition of [3,5-(CF3)2C6H3]3P and tolerates
phenyls with both electron-donating and electron-withdrawing
groups.
In a further application, Wang et al. applied chiral bis-
borane catalysts in the asymmetric reduction of 2-vinyl-sub-
stituted pyridines.78 In this procedure, hydroboration of the
substituted pyridine occurs first to give a dihydropyridine
intermediate which is subsequently converted to the enan-
tiopure product through asymmetric transfer hydrogenation
using borane 51. A range of 2-styryl-substituted pyridines
were asymmetrically reduced in high ee, Fig. 64, as well as
both conjugated and unconjugated double and triple
bonds. In a comparative study with metal-catalysed hydro-
genations it was found that these resulted in the reduction
of both the pyridine and olefin. The method was also
applied on a gram scale of two 2-vinyl-substituted
pyridines.
5. Conclusions
In summary, a variety of methods have been applied to the
reduction of CvN bonds using AH, ATH and organocatalytic
reagents. To date, significant breakthroughs have been
achieved in the reduction of CvN bonds using a wide range of
catalysts, ligands, hydrogen sources and solvents. Asymmetric
reductions benefits from the right design of catalyst, choice of
hydrogen source, solvents etc. and the diversity of methods
which has been applied to this transformation is very impress-
ive, and highly innovative. Several approaches are now avail-
able to the synthetic chemist and many of them are very
general. The application of asymmetric CvN reduction has a
major role in obtaining chiral fine chemicals, bioactive phar-
maceuticals intermediated and many target molecules.
Although significant research has been carried out on imine
reduction using a variety of methods, the combination of this
with other processes including cascade reactions could offer
new discoveries in the near future.
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Fig. 63 Chiral bicyclic bisborane catalysts for asymmetric quinoline hydrogenation.
Fig. 64 Chiral bisborane catalysts applied to the asymmetric reduction of 2-vinyl-substituted pyridines.
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